Is denosumab associated with an increased risk for infection in patients with low bone mineral density? A systematic review and meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Is denosumab associated with an increased risk for infection in patients with low bone mineral density? A systematic review and meta‐analysis of randomized controlled trials

Published:2021-04 Issue:7 Volume:24 Page:869-879
ISSN:1756-1841
Container-title:International Journal of Rheumatic Diseases
language:en
Short-container-title:Int J Rheum Dis

Author:

Catton Brett¹^ORCID,Surangiwala Salman²,Towheed Tanveer¹

Affiliation:

1. Division of Rheumatology Queen’s University Kingston ON Canada

2. Queen’s School of Medicine Kingston ON Canada

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1756-185X.14101

Reference39 articles.

1. Role of RANK Ligand and Denosumab, a targeted RANK ligand inhibitor, in bone health and osteoporosis: a review of preclinical and clinical data;Dempster DW;J Clinthera,2012

2. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

3. Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*

4. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy

5. OSTEOIMMUNOLOGY: Interplay Between the Immune System and Bone Metabolism

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials;Osteoporosis International;2024-05-11

2. Treatment of osteoporosis: Inhibitors of bone resorption;Reference Module in Biomedical Sciences;2024

3. Denosumab. ¿Dónde estamos?;Revista Española de Anestesiología y Reanimación;2023-06

4. Denosumab - Where are we?;Revista Española de Anestesiología y Reanimación (English Edition);2023-06

5. POS0295 OCCURRENCE OF SERIOUS INFECTIONS IN RHEUMATOID ARTHRITIS PATIENTS CONCURRENTLY TREATED WITH A BIOLOGIC AGENT AND DENOSUMAB: A RETROSPECTIVE STUDY WITH PROPENSITY SCORE;Annals of the Rheumatic Diseases;2022-05-23